J.B. Chemicals (JBCHEPHARM) | Stock Overview & Key Data
J.B. Chemicals Performance Comparison
Stock Range
Today's Range
Low: ₹1,644.60
High: ₹1,668.50
on October 6, 2025
52 Week Range
Low: ₹1,385.75
High: ₹1,984.00
on April 7, 2025
on November 1, 2024
All-Time High: ₹2,937.00 on August 28, 2023
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR261.4B
EPS
43.21
P/E Ratio (TTM)
38.29
Forward P/E
27.32
P/B Ratio
7.50
PEG Ratio
2.73
Div. Yield
1.25%
ROE
19.21%
Beta
-0.086
Debt to Equity
0.81
Financial Highlights
Profitability
Gross Margin
68.27%
Operating Margin
23.60%
Profit Margin
17.10%
Returns and Earnings
Return on Assets (TTM)
15.43%
Return on Equity (TTM)
19.21%
EBITDA
INR11.0B
Net Income (TTM)
INR6.9B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR257.43
Quarterly Revenue Growth (YoY)
8.90%
Quarterly Earnings Growth (YoY)
14.40%
Dividend Information
Last 12-Month Dividend
₹22.25
Current Dividend Yield
1.25%
3-Year Average Dividend Yield
0.26%
3-Year Average Annual Dividend
₹12.93
3-Year Total Dividends
₹38.80
Ex-Dividend Date
July 30, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| J.B. Chemicals JBCHEPHARM | 261.35B Large-cap | -2.72% | -3.85% | 1.59% | 9.29% | -11.68% | -8.17% | -14.17% | 58.27% |
| Sun Pharmaceutical SUNPHARMA | 4.01T Large-cap | 4.12% | 4.66% | -1.50% | -0.70% | -12.45% | -13.00% | 69.49% | 239.84% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | 2.26% | -3.33% | -15.42% | 10.79% | -4.06% | -5.14% | 63.08% | 80.80% |
| Cipla CIPLA | 1.23T Large-cap | 1.75% | -1.76% | 0.23% | 9.34% | 2.34% | 5.18% | 36.53% | 93.52% |
| Torrent TORNTPHARM | 1.21T Large-cap | -1.69% | -2.41% | 5.18% | 9.04% | 3.14% | 0.83% | 121.06% | 28.49% |
| Dr. Reddy's DRREDDY | 1.05T Large-cap | 1.13% | -0.16% | -4.72% | 14.77% | -8.79% | -5.40% | 44.82% | 22.88% |
Ownership & Short Interest
Insider Ownership
48.00%
Institutional Ownership
31.94%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
122K
Average 90-Day Volume
119K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is JBCHEPHARM's 52-week high and low?
- In the last 52 weeks, J.B. Chemicals reached a high of ₹1,984.00 (on November 1, 2024) and a low of ₹1,385.75 (on April 7, 2025).
- What is the market cap and P/E ratio for JBCHEPHARM?
- Curious about J.B. Chemicals's size and valuation? Its market capitalization stands at 261.35B. When it comes to valuation, the P/E ratio (trailing twelve months) is 38.29, and the forward P/E (looking ahead) is 27.32.
- Does JBCHEPHARM pay dividends? If so, what's the yield?
- Yes, J.B. Chemicals is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.25%, and the company has paid an average of ₹12.93 per share annually over the past 3 years.
- Who are J.B. Chemicals's main competitors or similar companies to consider before investing?
When looking at J.B. Chemicals, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA4.01T Healthcare Drug Manufacturers - Specialty & Generic -13.00% 69.49% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic -5.14% 63.08% Cipla
CIPLA1.23T Healthcare Drug Manufacturers - Specialty & Generic 5.18% 36.53% Torrent
TORNTPHARM1.21T Healthcare Drug Manufacturers - Specialty & Generic 0.83% 121.06% Dr. Reddy's
DRREDDY1.05T Healthcare Drug Manufacturers - Specialty & Generic -5.40% 44.82% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for J.B. Chemicals & Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of J.B. Chemicals's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.21%, the Debt to Equity ratio from the most recent quarter is 0.81, and its Gross Profit Margin stands at 68.27%.
- What is the recent revenue and earnings growth for JBCHEPHARM?
- Looking at J.B. Chemicals's growth, its revenue over the trailing twelve months (TTM) was INR40B. Compared to the same quarter last year (YoY), quarterly revenue grew by 8.90%, and quarterly earnings saw a YoY growth of 14.40%.
- How much of JBCHEPHARM stock is held by insiders and institutions?
- Wondering who owns J.B. Chemicals stock? Company insiders (like executives and directors) hold about 48.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 31.94%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.